• Pharma Regulatory Services in Japan

    Overview

    As part of the international multicentre development programs, global pharmaceutical companies are turning towards Japan for conducting clinical trials. That shows a great sign for drug development in Japan. To be a part of the Japan’s pharmaceutical market, however, foreign drug developers need to balance great advantages of country’s growing market opportunities with that of the stringent registration and Regulatory pathways laid out by the Pharmaceuticals and Medical Devices Agency (PMDA), country’s Health Authority.

  • Regulatory Services in Japan

    Overview

    With a comprehensive Regulatory framework, Japan stands a competitive market for foreign medicinal and medical devices manufacturers while investing in the region. Not only the stringent regulations inclusive of language barriers, but also the expensive Regulatory procedural challenges demand a special attention from manufacturers, who are willing to enter the region. To get the market access, manufacturers must comply with Japan’s Pharmaceutical and Medical Device Act (PMD Act), which is regulated by the Pharmaceutical and Medical Devices Agency (PMDA).